One of the examined mice receiving 32D-FLT3ITD AML cells and the pre-incubated graft showed a lower amount of CD135+ events but an increased count for CD8+ events, whereas the results were reversed in a second mouse. This evidence concerns the gene FLT3 and acute myeloid leukemia.